Actelion issues invitation to 2014 Annual General Meeting of Shareholders
Thomson Reuters ONE - Fri Apr 11, 12:01AM CDT
Actelion Pharmaceuticals Ltd / Actelion issues invitation to 2014 Annual General Meeting of Shareholders . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
The Medicines Co's Fibrocaps Under U.S. Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 5:08PM CDT
The FDA accepted the biologic license application (BLA) for The Medicines Co.'s dry powder formulation of Fibrocaps.
Weakness Seen in Kindred Biosciences (KIN): Stock Tumbles 9.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 7:48AM CDT
Kindred Biosciences, Inc. (KIN) saw a big move last session`,continuing the recent downtrend for KIN, as the stock is now down more than 28.0% in the past one-month time frame.
Good News for Keryx - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 5:20PM CDT
Keryx Biopharmaceuticals received good news when the European Medicines Agency (EMA) determined its Marketing Authorization Application (MAA) for lead candidate Zerenex as valid.
Myriad Genetics Jumps on Medicare Decision - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 1:50PM CDT
Shares of Myriad Genetics gained 11.47% on yesterday's close.
Myriad Genetics (MYGN) Worth Watching: Stock Rises 11.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 8:25AM CDT
Myriad Genetics was a big mover last session, with shares rising over 11% on the day.
What Falling Estimates & Price Mean for bluebird bio (BLUE) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 7:43AM CDT
One such stock that you may want to consider dropping is bluebird bio which witnessed negative earnings estimate revisions in current quarter and current year.
Bayer's Adempas Cleared in the EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 3:45PM CDT
Bayer's Adempas was approved in the EU for the CTEPH and PAH indications.
Ultragenyx (RARE) Jumps: Stock Rises 7.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 8:46AM CDT
Ultragenyx was a big mover last session, with shares rising 7% on the day.
Cara Therapeutics Inc. (CARA) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 7:57AM CDT
Cara Therapeutics Inc. was a big mover last session, as the company saw its shares rise nearly 13% on the day.
Keryx Biopharmaceuticals Inc. (KERX) Worth Watching: Stock Surges 17.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:44AM CDT
Keryx Biopharmaceuticals Inc. was a big mover last session, as the company saw its shares shoot up over 17% on the day.
Galectin Therapeutics, Inc. (GALT) in Focus: Stock Moves Up 8.84% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:44AM CDT
Galectin Therapeutics, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day.
Favorable Data for Myriad Genetics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 2:30PM CDT
Shares of Myriad Genetics gained 1.78% at yesterday's close.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:44AM CDT
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise 9.5% on the day.
Fate Reports In-Line Loss in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 1:28PM CDT
Share price of Fate Therapeutics (FATE) gained 10.3% after the company released fourth quarter earnings but lost 4.0% in the next trading session. Overall, shares gained 6.15% following the fourth quarter results.
Palatin Technologies (PTN) Worth Watching: Stock Soars 15.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 8:25AM CDT
Palatin was a big mover last session, with shares rising nearly 16% on the day.
Synthetic Biologics Inc. (SYN) in Focus: Stock up 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 8:04AM CDT
Synthetic Biologics Inc. was a big mover last session, as the company saw its shares rise over 9% on the day
Oncothyreon Inc. (ONTY) in Focus: Stock up 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:44AM CDT
Oncothyreon Inc. was a big mover last session, as the company saw its shares rise slightly over 6% on the day.
Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 8:46AM CDT
GTX was a big mover last session, with shares rising nearly 9% on the day.
Durata Therapeutics, Inc. (DRTX) in Focus: Stock Up 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 7:44AM CDT
Durata Therapeutics, Inc. was a big mover last session, as the company saw its shares jump 5.4% on the day.